215057-28-6Relevant articles and documents
NOVEL COMPOUNDS AND USES
-
Page/Page column 60-62, (2018/12/13)
The present invention relates to compounds of formula (I): wherein Q is O or S; R1 is a cyclic group substituted with at least one group X, wherein R1 may optionally be further substituted; X is any group comprising a carbonyl group; and R2 is a cyclic group substituted at the α-position, wherein R2 may optionally be further substituted. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the dual action of NLRP3 inhibition and the stimulation of insulin secretion.
SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME
-
Page/Page column 149; 150, (2016/09/15)
ABSTRACT The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in the treatment of a wide range of disorders in which the inflammation process, or more specifically the NLRP3 inflammasome, have been implicated as being a key factor.
PROCESS FOR THE SYNTHESIS OF RAMELTEON AND ITS INTERMEDIATES
-
Page/Page column 5; 6; 14; 20; 36; 46; 63; 68, (2009/01/24)
The present invention provides processes and intermediates for the synthesis of ramelteon.